Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer

Visit http://www.ecancer.org for more.

Prof Rakovitch (Sunnybrook Research Institute, Toronto, Canada) talks to ecancertv at SABCS 2014 about the use of a multigene test called Oncotype DX DCIS Score (DCIS Score) which seeks to predict of risk of disease recurrence for patients with ductal carcinoma in situ (DCIS).

• 类别